BioNexus Gene Lab Corp.

US$0.83As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BGLCMaterials
Country USA
PE (Fwd) •••
TSR 6Y CAGR (58.57%)
Div yield —
ROE (33.66%)
Specialty Chemicals
Beta (5Y) 1.97
PE TTM —
TSR TTM (84.69%)
Mkt cap US$2.435M
ROIC (60.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.843
1.54%
(61.75%)
Buy 7|4|12|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
20.06%
19.85%
12.12%
14.57%
Revenue$M
0.143
0.147
0.143
0.151
6.17%
8.87%
1.29%
3.91%
Peers (US$2.435M)
Cap (US$)
PE
9.233M
10.00x
6.942M
—
2.202M
—
Capital
TTM
5Y
10Y
Leveragex
2.695
(1.219)
(1.153)
EBIT/Intx
4.030
0.194
0.153
Own earn%
13.98
(66.20)
(41.78)
Sh yield%
16.05
47.82
46.24
Owners
Insiders/Inst%
13.11
36.84
Short interest%
2.44
SBC / revenue%
1.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
12–21
$1 testx
0.0
Incr. ROIC%
3